Industry update MediPharm reports 89% one-year revenue decline The Ontario-based cannabis extractor will cut 30% of its workforce as third-quarter sales fell to $4.9 million Jared GnamNovember 16, 2020
Industry update Pure Sunfarms books 7th straight quarter of profits BC-based Village Farms says its cannabis business has a 13.6% market share in the Ontario recreational market Jared GnamNovember 13, 2020
Canada How a wave of irradiation could hurt Canadian micro-producers Incoming lower microbial limits could force small growers to irradiate their product, hiking costs and hurting quality in the process Jared GnamNovember 13, 2020
Analysis New Jersey: The East Coast cannabis tipping point Legalizing in the Garden State increases revenue and access for its citizens, and seeds jealousy in states struggling next door Amna ShamimNovember 13, 2020
Industry update Village Farms landfill gas project to cut 28,000 tonnes of CO2 annually The owner of Pure Sunfarms says it's renewed a contract with the City of Vancouver that repurposes landfill gas to significantly reduce its use... Nick LabaNovember 12, 2020
Industry update First research to see if smoking weed while pregnant affects babies’ brain development University of Saskatchewan researchers hypothesize high THC increases anxiety, while reducing cognition and sociability Nick LabaNovember 10, 2020
Industry update Despite mixed Q1 results, Aurora soars on Biden victory Company stock has surged more than 150% since Nov. 5, even while reporting declining Canadian weed sales Jared GnamNovember 9, 2020
Canada Canopy celebrates rising Canadian sales and Biden win The Ontario-based super-producer saw Q2 sales grow 23% while it adjusted its US expansion strategy for a Democrat in the White House Jared GnamNovember 9, 2020
Canada Talking pain and cannabis with Canopy’s head of medicine: Q&A As part of National Pain Awareness Week, Canopy's chief medical officer discusses how Canadians are navigating chronic pain with weed Nick LabaNovember 7, 2020
Psychedelics Psilocybin therapy 4 times more effective than antidepressants: study A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound Jared GnamNovember 6, 2020